Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Industry News

Cardiac Dimensions Announces Investigational Device Exemption Approval from FDA to Conduct U.S. Pivotal Study of the Carillon Mitral Contour System for Functional Mitral Regurgitation

December 01, 2016

News Conference News AHA 2016

Stark Mortality Differences Seen in GARY Registry Tracking TAVR and Surgical Replacement

Shelley Wood

November 14, 2016

News Conference News

Watchman, Amulet LAA Closure Devices Carry Low Complication Rates

Todd Neale

November 04, 2016

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

News Conference News PCR London Valves 2016

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

Shelley Wood

September 20, 2016

News Conference News TVT 2016

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Michael O'Riordan

June 20, 2016

News Conference News TVT 2016

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Michael O'Riordan

June 20, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

News Conference News EuroPCR 2012

TAVR Studies Tease Out Influences on Clinical Outcome

Caitlin E. Cox

May 18, 2012

News Daily News

Studies Suggest 3-D CT Prior to TAVR Should Be ‘Gold Standard’

Yael L. Maxwell

March 07, 2012

News Daily News

FDA Approves Sapien Transcatheter Valve for Inoperable Aortic Stenosis

Yael L. Maxwell

November 03, 2011

News Daily News

PARTNER: Quality of Life Greatly Improved by Transcatheter Valve Procedure

October 06, 2011

News Daily News

NEJM Letters Take on PARTNER Trial

Caitlin E. Cox

January 11, 2011

News Daily News

Consensus TAVI Endpoint Definitions Raise Standard of Research in New Field

January 11, 2011

News Daily News

Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress

Caitlin E. Cox

January 02, 2011

News

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

TCT Daily Staff

September 23, 2010

Advertisement

Cardiac Dimensions Announces Investigational Device Exemption Approval from FDA to Conduct U.S. Pivotal Study of the Carillon Mitral Contour System for Functional Mitral Regurgitation

Stark Mortality Differences Seen in GARY Registry Tracking TAVR and Surgical Replacement

Watchman, Amulet LAA Closure Devices Carry Low Complication Rates

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

What TAVR Needs Next . . . and What It’s Getting

TAVR Studies Tease Out Influences on Clinical Outcome

Studies Suggest 3-D CT Prior to TAVR Should Be ‘Gold Standard’

FDA Approves Sapien Transcatheter Valve for Inoperable Aortic Stenosis

PARTNER: Quality of Life Greatly Improved by Transcatheter Valve Procedure

NEJM Letters Take on PARTNER Trial

Consensus TAVI Endpoint Definitions Raise Standard of Research in New Field

Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content